Welcome to the eighth issue of our report, “Mpox: Transparency and Accountability for the Global Response.”
In this edition, we provide a comprehensive update on the latest developments and insights across all topic areas, featuring our most recent analyses and findings since the last issue. This report will be updated and shared every other week with our community.
Latest updates at a glance:
- The United States reported a new case of clade 1b mpox on February 11th. In New York. The patient recently traveled to Africa and is currently under isolating until symptom resolution. The risk to the general public remains low at this time. This is the fourth case (three prior cases in California, Georgia, and New Hampshire) of clade 1b mpox detected in the U.S. since the start of the outbreak in 2024.
- On February 8th, South Sudan reported its first confirmed mpox case of clade I in a Ugandan national who had recently returned from a trip to Uganda. On February 13th, the UAE reported its first case of clade Ib mpox in apatient with recent travel to Uganda.
- Rwanda received a delivery of 5,800 doses additional mpox vaccine doses on February 7th.
- On February 14th, the DRC received 200,000 mpox vaccine doses and Cote d’Ivoire received 11,300 vaccine doses.
- On February 18th, the Central African Republic received 10,000 mpox vaccine doses.
As always, we aim to serve as an external, independent source for tracking and catalyzing effective actions to meet and increase commitments, and to hold the key stakeholders to account for achieving emergency preparedness and response goals.